Epistaxis - 27 Studies Found

Active, not recruiting : Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
:
  • Hereditary Hemorrhagic Telangiectasia
  • Epistaxis

: 2011-11-28
: Drug: Thalidomide Eligible patients will receive thalidomi
Withdrawn : Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
:
  • Hereditary Hemorrhagic Telangiectasia (HHT)
  • Nosebleeds
    • : 2011-07-29
    : Drug: Ranibizumab Patients will be treated with a total of 4 applications of ranibizumab in a fine mist
Recruiting : Intranasal Bevacizumab for HHT-Related Epistaxis
:
  • HHT
  • Hereditary Hemorrhagic Telangiectasia
  • Drug: Bevacizumab Bevacizumab

Completed : Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
:
  • HHT
  • Morbus Osler
  • Epistaxis : 2011-03-09
    :
    • Drug: Bevacizumab 100mg intran
Recruiting : The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.
:
  • Epistaxis
  • Blood Pressure

: 2014-11-05
:
  • Drug: Oxymetazoline 0.05% ster
RECRUITING : Nasal Compression Device Study for Epistaxis
: Epistaxis Nosebleed
: 2024-11-21
: Participants assigned to the NasaClip arm will not receive routine care as the objective of this study is to compare the NasaClip device to routine di
RECRUITING : Cauterization of the Anterior Ethmoidal Artery by Transconjunctival Approach
: Epistaxis, Anterior Ethmoid Artery
: 2024-11-21
<<< Previous